Valsartan Injury Lawyers
Mazie Slater Katz & Freeman is currently investigating valsartan cancer claims. Valsartan is a blood pressure medication that was recently recalled by multiple companies over concerns the drug may be contaminated with a cancer-causing substance, going back at least four years. The recalls were prompted by the discovery that valsartan produced in a certain facility in China by Zhejiang Huahai Pharmaceuticals contained a carcinogen called N-nitrosodimethylamine (NDMA). Valsartan medications are used to treat high blood pressure.
The Food and Drug Administration (FDA) has received several adverse event reports from patients, and we are investigating serious medical conditions, including:
- Liver cancer
- Kidney cancer and renal cancer
- Stomach cancer
- Gastrointestinal cancer
- Metastatic cancer to lungs, colon, brain, pelvic organs
- Metastases to the liver
On July 13, 2018, the FDA advised in a press release that after a careful assessment, the valsartan-containing medications at issue do not meet the agency’s safety standards and urged companies to take immediate action to protect patients.
Days later voluntary recalls were initiated by multiple pharmaceutical companies including:
- Teva Pharmaceuticals
- Teva Pharmaceuticals USA
- Major Pharmaceuticals
- Prinston Pharmaceuticals
- Soco Healthcare LLC
- Torrent Pharmaceutical
- Camber Pharmaceutical
Most of the companies involved in Valsartan cancer recall are based in New Jersey, where Mazie Slater is based and has led multiple large litigations against pharmaceutical and medical device companies. If you or someone you know has a potential valsartan cancer claim, contact one of our qualified valsartan attorneys today so that we can evaluate your valsartan claim.